Use of Cell-Free Fetal DNA in Maternal Plasma for Noninvasive Prenatal Screening

被引：12

作者：

Wagner, Amy J. ^{[1
]}

Mitchell, Michael E. ^{[2
]}

Tomita-Mitchell, Aoy ^{[2
]}

机构：

[1] Med Coll Wisconsin, Div Pediat Surg, Dept Surg, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, Milwaukee, WI 53226 USA

来源：

CLINICS IN PERINATOLOGY | 2014年 / 41卷 / 04期

关键词：

Noninvasive prenatal testing; Screening; Cell-free DNA; Aneuploidy; DOWN-SYNDROME; CLINICAL-APPLICATION; ANEUPLOIDY; DIAGNOSIS; BLOOD; SERUM; 1ST-TRIMESTER; AMNIOCENTESIS; PREGNANCIES; TRISOMY-21;

D O I：

10.1016/j.clp.2014.08.013

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Noninvasive prenatal testing (NIPT) using cell-free fetal (cfDNA) offers potential as a screening tool for fetal anomalies. All pregnant women should be offered prenatal screening and diagnostic testing based on current guidelines. Adoption of NIPT in high-risk pregnancies suggests a change in the standard of care for genetic screening; there are advantages to an accurate test with results available early in pregnancy. This accuracy decreases the overall number of invasive tests needed for diagnosis, subjecting fewer pregnancies to the risks of invasive procedures. Women undergoing NIPT need informed consent before testing and accurate, sensitive counseling after results are available.

引用

页码：957 / +

页数：11

共 50 条

[41] Cell-free fetal mRNAs are stable markers for noninvasive prenatal screening of trisomy 21
Xu, Yajuan
Zhang, Yingying
Luo, Xiaohua
Zhai, Shanshan
Ran, Limin
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3752 - 3757
[42] Application of Fetal DNA in Maternal Plasma in Noninvasive Prenatal Diagnosis
赵茵
邹丽
华中科技大学学报(医学英德文版), 2004, (01) : 59 - 61
[43] Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening
Rink, Britton D.
Stevens, Blair K.
Norton, Mary E.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (01) : 17 - 19
[44] Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening
Rink, Britton D.
Stevens, Blair K.
Norton, Mary E.
OBSTETRICS AND GYNECOLOGY, 2022, 140 (01): : 121 - 131
[45] CIRCULATING CELL-FREE FETAL DNA IN MATERNAL PLASMA: PROSPECTS FOR NON-INVASIVE PRENATAL ASSESSMENT OF FETAL ANEUPLOIDIES
van den Boom, D.
Ehrich, M.
Deciu, C.
Bombard, A.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S92 - S92
[46] Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma
Mazloom, Amin R.
Dzakula, Zeljko
Oeth, Paul
Wang, Huiquan
Jensen, Taylor
Tynan, John
McCullough, Ron
Saldivar, Juan-Sebastian
Ehrich, Mathias
van den Boom, Dirk
Bombard, Allan T.
Maeder, Margo
McLennan, Graham
Meschino, Wendy
Palomaki, Glenn E.
Canick, Jacob A.
Deciu, Cosmin
PRENATAL DIAGNOSIS, 2013, 33 (06) : 591 - 597
[47] Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis
Ariga, H
Ohto, H
Busch, MP
Imamura, S
Watson, R
Reed, W
Lee, TH
TRANSFUSION, 2001, 41 (12) : 1524 - 1530
[48] Cell-free fetal DNA-based noninvasive prenatal testing of aneuploidy reply
Mackie, Fiona L.
Allen, Stephanie
Morris, R. Katie
Kilby, Mark D.
OBSTETRICIAN & GYNAECOLOGIST, 2018, 20 (01): : 69 - 70
[49] A Size-Selective DNA Extraction Method Enriching Circulating Cell-Free Fetal DNA from Maternal Plasma for Noninvasive Prenatal Diagnostic (NIPD) Assays
van den Boom, D.
Horlitz, M.
Lucas, A.
Hartinger, T.
Krueger, N.
Ritt, C.
Oeth, P.
Ehrich, M.
Angkachatchai, V.
Sprenger-Haussels, M.
Dragon, B.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 571 - 571
[50] Clinical applications of cell-free fetal DNA from maternal plasma
Rijnders, RJP
Christiaens, GCML
Bossers, B
van der Smagt, JJ
van der Schoot, CE
de Haas, M
OBSTETRICS AND GYNECOLOGY, 2004, 103 (01): : 157 - 164

← 1 2 3 4 5 →